Â鶹ѧÉú¾«Æ·°æ

Bob S. Carter
No Rating Available
(Learn About Our Rating System)

Bob S. Carter, MD, PhD, FAANS

Chief Executive Officer, Â鶹ѧÉú¾«Æ·°æ; Senior Vice President, Â鶹ѧÉú¾«Æ·°æ Sciences

Languages spoken: English

Clinical Locations

Clinical Neurosciences Center

Salt Lake City
801-585-7575

  • Bob S. Carter, MD, PhD, serves as senior vice president for health sciences and CEO for Â鶹ѧÉú¾«Æ·°æ. In his roles leading the health system, Carter works to ensure the professional and educational success of more than 27,000 talented faculty, staff, and students who make U of U Health one of the nation’s premier academic health centers. 

    Academic & Clinical Expertise

    Prior to joining the University of Utah in 2025, he served as the William and Elizabeth Sweet Endowed Professor in Neuroscience at Harvard Medical School and Neurosurgeon-In-Chief at Mass General Brigham, Massachusetts General Hospital and Brigham and Women’s Hospital. 

    A neurosurgical oncologist and prolific researcher, Carter was elected to the National Academy of Medicine in 2024. Carter received an MD and PhD in epidemiology from Johns Hopkins University and an undergraduate degree in chemistry from Brigham Young University. 

    Learn more about Dr. Carter. .

    Specialties

  • Board Certification and Academic Information

    Academic Departments Neurosurgery -Professor

    Education history

    Graduate Training Harvard University M.A.
    Residency North Neurosurgical Service - Massachusetts General Hospital Chief Resident
    Fellowship Gene Therapy - Massachusetts Institute of Technology & Boston Children’s Hospital Postdoctoral Fellow
    Residency Neurosurgery - Massachusetts General Hospital Resident
    Internship Surgery - Massachusetts General Hospital Intern
    Graduate Training Genetic Epidemiology - Johns Hopkins University School of Public Health Ph.D.
    Professional Medical Medicine - Johns Hopkins University School of Medicine M.D.
    Undergraduate Chemistry - Brigham Young University B.A.

    Selected Publications

    Journal Article

    1. Massaad E, Smith WJ, Bradley J, Esposito E, Gupta M, Burns E, Burns R, Velarde JK, Berglar IK, Gupta R, Martinez-Lage M, Dietrich J, Lennerz JK, Dunn GP, Jones PS, Choi BD, Kim AE, Frosch M, Barker FG, Curry WT, Carter BS, Nahed BV, Cahill DP, Shankar GM (2024). Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma. Neuro Oncol, 26(9), 1660-1669. ()
    2. Wang AZ, Mashimo BL, Schaettler MO, Sherpa ND, Leavitt LA, Livingstone AJ, Khan SM, Li M, Anzaldua-Campos MI, Bradley JD, Leuthardt EC, Kim AH, Dowling JL, Chicoine MR, Jones PS, Choi BD, Cahill DP, Carter BS, Petti AA, Johanns TM, Dunn GP (2023). Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population. Cancer Discov, 14(6), 1106-1131. ()
    3. Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV (2024). Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. N Engl J Med, 390(14), 1290-1298. ()
    4. Hsia T, You DG, Politis MG, Batool SM, Ekanayake E, Lee H, Carter BS, Balaj L (2023). Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization. Adv Biol (Weinh), 8(1), e2300233. ()
    5. Zhao S, Mekbib KY, van der Ent MA, Allington G, Prendergast A, Chau JE, Smith H, Shohfi J, Ocken J, Duran D, Furey CG, Hao LT, Duy PQ, Reeves BC, Zhang J, Nelson-Williams C, Chen D, Li B, Nottoli T, Bai S, Rolle M, Zeng X, Dong W, Fu PY, Wang YC, Mane S, Piwowarczyk P, Fehnel KP, See AP, Iskandar BJ, Aagaard-Kienitz B, Moyer QJ, Dennis E, Kiziltug E, Kundishora AJ, DeSpenza T Jr, Greenberg ABW, Kidanemariam SM, Hale AT, Johnston JM, Jackson EM, Storm PB, Lang SS, Butler WE, Carter BS, Chapman P, Stapleton CJ, Patel AB, Rodesch G, Smajda S, Berenstein A, Barak T, Erson-Omay EZ, Zhao H, Moreno-De-Luca A, Proctor MR, Smith ER, Orbach DB, Alper SL, Nicoli S, Boggon TJ, Lifton RP, Gunel M, King PD, Jin SC, Kahle KT (2023). Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. Nat Commun, 14(1), 7452. ()
    6. Ramapriyan R, Ramesh T, Yu H, Richardson LG, Nahed BV, Carter BS, Barker FG, Curry WT, Choi BD (2023). County-level disparities in care for patients with glioblastoma. Neurosurg Focus, 55(5), E12. ()
    7. Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, Escobedo AK, You DG, Castro CM, Im H, Kilic T, Garlin MA, Skog J, Dinulescu DM, Dudley J, Agrawal N, Cheng J, Abtin F, Aberle DR, Chia D, Elashoff D, Grognan T, Krysan K, Oh SS, Strom C, Tu M, Wei F, Xian RR, Skates SJ, Zhang DY, Trinh T, Watson M, Aft R, Rawal S, Agarwal A, Kesmodel SB, Yang C, Shen C, Hochberg FH, Wong DTW, Patel AA, Papadopoulos N, Bettegowda C, Cote RJ, Srivastava S, Lee H, Carter BS, Balaj L (2023). The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell Rep Med, 4(10), 101198. ()
    8. Batool SM, Hsia T, Beecroft A, Lewis B, Ekanayake E, Rosenfeld Y, Escobedo AK, Gamblin AS, Rawal S, Cote RJ, Watson M, Wong DTW, Patel AA, Skog J, Papadopoulos N, Bettegowda C, Castro CM, Lee H, Srivastava S, Carter BS, Balaj L (2023). Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer. Cell Rep Med, 4(10), 101196. ()
    9. Yekula A, Hsia T, Kitchen RR, Chakrabortty SK, Yu W, Batool SM, Lewis B, Szeglowski AJ, Weissleder R, Lee H, Chi AS, Batchelor T, Carter BS, Breakefield XO, Skog J, Balaj L (2023). Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients. Neurooncol Adv, 5(1), vdad104. ()
    10. Hsia T, Small JL, Yekula A, Batool SM, Escobedo AK, Ekanayake E, You DG, Lee H, Carter BS, Balaj L (2023). Systematic Review of Photodynamic Therapy in Gliomas. Cancers (Basel), 15(15). ()
    11. Yekula A, Sreeram S, Dhawan S, Sharma M, Sandoval-Garcia C, Huling JD, Suri A, Belani K, Park MC, Carter BS, Chen CC (2023). Neurosurgery residency match for international medical graduates in the United States. J Neurosurg, 140(1), 291-298. ()
    12. Park TY, Jeon J, Lee N, Kim J, Song B, Kim JH, Lee SK, Liu D, Cha Y, Kim M, Leblanc P, Herrington TM, Carter BS, Schweitzer JS, Kim KS (2023). Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease. Nature, 619(7970), 606-615. ()
    13. Hsia T, Yekula A, Batool SM, Rosenfeld YB, You DG, Weissleder R, Lee H, Carter BS, Balaj L (2022). Glioblastoma-derived extracellular vesicle subpopulations following 5-aminolevulinic acid treatment bear diagnostic implications. J Extracell Vesicles, 11(11), e12278. ()
    14. Batool SM, Muralidharan K, Hsia T, Falotico S, Gamblin AS, Rosenfeld YB, Khanna SK, Balaj L, Carter BS (2022). Highly Sensitive EGFRvIII Detection in Circulating Extracellular Vesicle RNA of Glioma Patients. Clin Cancer Res, 28(18), 4070-4082. ()
    15. Yeo AT, Rawal S, Delcuze B, Christofides A, Atayde A, Strauss L, Balaj L, Rogers VA, Uhlmann EJ, Varma H, Carter BS, Boussiotis VA, Charest A (2022). Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. Nat Immunol, 23(6), 971-984. ()
    16. Choi BD, Carter BS (2022). Engineering Our Future: Advancing Cell and Gene Therapy in Neurosurgery. Neurosurgery, 68(Suppl 1), 11-16. ()
    17. Duy PQ, Weise SC, Marini C, Li XJ, Liang D, Dahl PJ, Ma S, Spajic A, Dong W, Juusola J, Kiziltug E, Kundishora AJ, Koundal S, Pedram MZ, Torres-Fernndez LA, Hndler K, De Domenico E, Becker M, Ulas T, Juranek SA, Cuevas E, Hao LT, Jux B, Sousa AMM, Liu F, Kim SK, Li M, Yang Y, Takeo Y, Duque A, Nelson-Williams C, Ha Y, Selvaganesan K, Robert SM, Singh AK, Allington G, Furey CG, Timberlake AT, Reeves BC, Smith H, Dunbar A, DeSpenza T Jr, Goto J, Marlier A, Moreno-De-Luca A, Yu X, Butler WE, Carter BS, Lake EMR, Constable RT, Rakic P, Lin H, Deniz E, Benveniste H, Malvankar NS, Estrada-Veras JI, Walsh CA, Alper SL, Schultze JL, Paeschke K, Doetzlhofer A, Wulczyn FG, Jin SC, Lifton RP, Sestan N, Kolanus W, Kahle KT (2022). Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus. Nat Neurosci, 25(4), 458-473. ()
    18. Kilic T, Cho YK, Jeong N, Shin IS, Carter BS, Balaj L, Weissleder R, Lee H (2022). Multielectrode Spectroscopy Enables Rapid and Sensitive Molecular Profiling of Extracellular Vesicles. ACS Cent Sci, 8(1), 110-117. ()
    19. Schupper AJ, Baron RB, Cheung W, Rodriguez J, Kalkanis SN, Chohan MO, Andersen BJ, Chamoun R, Nahed BV, Zacharia BE, Kennedy J, Moulding HD, Zucker L, Chicoine MR, Olson JJ, Jensen RL, Sherman JH, Zhang X, Price G, Fowkes M, Germano IM, Carter BS, Hadjipanayis CG, Yong RL (2021). 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study. J Neurosurg, 136(6), 1525-1534. ()
    20. Khalafallah AM, Rakovec M, Bettegowda C, Jackson CM, Gallia GL, Weingart JD, Lim M, Esquenazi Y, Zacharia BE, Goldschmidt E, Ziu M, Ivan ME, Venteicher AS, Nduom EK, Mamelak AN, Chu RM, Yu JS, Sheehan JP, Nahed BV, Carter BS, Berger MS, Sawaya R, Mukherjee D (2021). A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma. Neurosurgery, 89(4), 712-719. ()
    21. Simon MV, Curry WT, Jones PS, Cahill DP, Carter BS, Rapalino O, Malik AN, Nahed BV (2021). Intraoperative thalamocortical tract monitoring via direct cortical recordings during craniotomy. Clin Neurophysiol, 132(7), 1416-1432. ()
    22. Park J, Park JS, Huang CH, Jo A, Cook K, Wang R, Lin HY, Van Deun J, Li H, Min J, Wang L, Yoon G, Carter BS, Balaj L, Choi GS, Castro CM, Weissleder R, Lee H (2021). An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma. Nat Biomed Eng, 5(7), 678-689. ()
    23. Muhlestein WE, Monsour MA, Friedman GN, Zinzuwadia A, Zachariah MA, Coumans JV, Carter BS, Chambless LB (2020). Predicting Discharge Disposition Following Meningioma Resection Using a Multi-Institutional Natural Language Processing Model. Neurosurgery, 88(4), 838-845. ()
    24. Kang KM, Muralidharan K, Yekula A, Small JL, Rosh ZS, Jones PS, Carter BS, Balaj L (2021). Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis. Cancers (Basel), 13(6). ()
    25. Muralidharan K, Yekula A, Small JL, Rosh ZS, Kang KM, Wang L, Lau S, Zhang H, Lee H, Bettegowda C, Chicoine MR, Kalkanis SN, Shankar GM, Nahed BV, Curry WT, Jones PS, Cahill DP, Balaj L, Carter BS (2020). TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas. Clin Cancer Res, 27(1), 169-178. ()
    26. Maas SLN, van Solinge TS, Schnoor R, Yekula A, Senders JT, de Vrij J, Robe P, Carter BS, Balaj L, Arkesteijn GJA, Nolte-t Hoen ENM, Broekman MLD (2020). Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients. Cancers (Basel), 12(11). ()
    27. Workman AD, Jafari A, Welling DB, Varvares MA, Gray ST, Holbrook EH, Scangas GA, Xiao R, Carter BS, Curry WT, Bleier BS (2020). Airborne Aerosol Generation During Endonasal Procedures in the Era of COVID-19: Risks and Recommendations. Otolaryngol Head Neck Surg, 163(3), 465-470. ()
    28. Workman AD, Welling DB, Carter BS, Curry WT, Holbrook EH, Gray ST, Scangas GA, Bleier BS (2020). Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol, 10(7), 798-805. ()
    29. Steed TC, Treiber JM, Taha B, Engin HB, Carter H, Patel KS, Dale AM, Carter BS, Chen CC (2020). Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state. J Neurooncol, 148(3), 455-462. ()
    30. Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS (2020). Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. N Engl J Med, 382(20), 1926-1932. ()
    31. Wang L, Yekula A, Muralidharan K, Small JL, Rosh ZS, Kang KM, Carter BS, Balaj L (2020). Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma. Cancers (Basel), 12(5). ()
    32. Ramakrishnan V, Xu B, Akers J, Nguyen T, Ma J, Dhawan S, Ning J, Mao Y, Hua W, Kokkoli E, Furnari F, Carter BS, Chen CC (2020). Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas. EBioMedicine, 55, 102736. ()
    33. Schweitzer JS, Song B, Leblanc PR, Feitosa M, Carter BS, Kim KS (2018). Columnar Injection for Intracerebral Cell Therapy. Oper Neurosurg (Hagerstown), 18(3), 321-328. ()
    34. Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim KS (2019). Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models. J Clin Invest, 130(2), 904-920. ()
    35. Choi BD, Yu X, Castano AP, Darr H, Henderson DB, Bouffard AA, Larson RC, Scarf I, Bailey SR, Gerhard GM, Frigault MJ, Leick MB, Schmidts A, Sagert JG, Curry WT, Carter BS, Maus MV (2019). CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. J Immunother Cancer, 7(1), 304. ()
    36. Pulli B, Chapman PH, Ogilvy CS, Patel AB, Stapleton CJ, Leslie-Mazwi TM, Hirsch JA, Carter BS, Rabinov JD (2019). Multimodal cerebral arteriovenous malformation treatment: a 12-year experience and comparison of key outcomes to ARUBA. J Neurosurg, 133(6), 1792-1801. ()
    37. Lopez Ramos C, Williams JE, Bababekov YJ, Chang DC, Carter BS, Jones PS (2019). Assessing the Understandability and Actionability of Online Neurosurgical Patient Education Materials. World Neurosurg, 130, e588-e597. ()
    38. Jones PS, Yekula A, Lansbury E, Small JL, Ayinon C, Mordecai S, Hochberg FH, Tigges J, Delcuze B, Charest A, Ghiran I, Balaj L, Carter BS (2019). Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma. EBioMedicine, 48, 23-35. ()
    39. Choi BD, Yu X, Castano AP, Bouffard AA, Schmidts A, Larson RC, Bailey SR, Boroughs AC, Frigault MJ, Leick MB, Scarf I, Cetrulo CL, Demehri S, Nahed BV, Cahill DP, Wakimoto H, Curry WT, Carter BS, Maus MV (2019). CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat Biotechnol, 37(9), 1049-1058. ()
    40. Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suv ML (2019). An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell, 178(4), 835-849.e21. ()
    41. Dineen J, Maus DC, Muzyka I, See RB, Cahill DP, Carter BS, Curry WT, Jones PS, Nahed BV, Peterfreund RA, Simon MV (2019). Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mapping. Clin Neurophysiol, 130(6), 1058-1065. ()
    42. Rogers N, Hermiz J, Ganji M, Kaestner E, Kl K, Hossain L, Thunemann M, Cleary DR, Carter BS, Barba D, Devor A, Halgren E, Dayeh SA, Gilja V (2019). Correlation Structure in Micro-ECoG Recordings is Described by Spatially Coherent Components. PLoS Comput Biol, 15(2), e1006769. ()
    43. Alattar AA, Carroll KT, Bryant AK, Hirshman B, Joshi R, Carter BS, Harismendy O, Chen CC (2018). Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database. World Neurosurg, 121, e411-e418. ()
    44. Koga T, Li B, Figueroa JM, Ren B, Chen CC, Carter BS, Furnari FB (2018). Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development. Neuro Oncol, 20(10), 1310-1320. ()
    45. Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB, Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W, Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ, Gruber HE, Das A, Walbert T (2018). Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC. Neuro Oncol, 20(10), 1383-1392. ()
    46. Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim KS (2018). Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Prog Neurobiol, 168, 1-20. ()
    47. Kang KH, Schapira E, Niemierko A, Martinez-Lage M, Bussire MR, Yock TI, Loeffler JS, Butler WE, Carter BS, Shih HA (2018). The role of proton beam therapy in central neurocytoma: A single-institution experience. Pract Radiat Oncol, 8(5), e305-e311. ()
    48. Treiber JM, Steed TC, Brandel MG, Patel KS, Dale AM, Carter BS, Chen CC (2018). Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA). J Clin Neurosci, 55, 86-92. ()
    49. Hirshman BR, Wilson BR, Ali MA, Schupper AJ, Proudfoot JA, Goetsch SJ, Carter BS, Sinclair G, Bartek J Jr, Chiang V, Fogarty G, Hong A, Chen CC (2016). Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases. Neurosurgery, 83(2), 237-244. ()
    50. Hermiz J, Rogers N, Kaestner E, Ganji M, Cleary DR, Carter BS, Barba D, Dayeh SA, Halgren E, Gilja V (2018). Sub-millimeter ECoG pitch in human enables higher fidelity cognitive neural state estimation. Neuroimage, 176, 454-464. ()
    51. Sahin A, Sanchez C, Bullain S, Waterman P, Weissleder R, Carter BS (2018). Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. PLoS One, 13(7), e0199414. ()
    52. Alattar AA, Hirshman BR, McCutcheon BA, Chen CC, Alexander T, Harris J, Carter BS (2016). Risk Factors for Readmission with Cerebrospinal Fluid Leakage Within 30 Days of Vestibular Schwannoma Surgery. Neurosurgery, 82(5), 630-637. ()
    53. McCutcheon BA, Hirshman BR, Gabel BC, Heffner MW, Marcus LP, Cole TS, Chen CC, Chang DC, Carter BS (2017). Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998-2009. J Neurosurg, 128(5), 1578-1588. ()
    54. Alattar AA, Brandel MG, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen CC (2017). Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis. J Neurosurg, 128(4), 1076-1083. ()
    55. Hirshman BR, Wilson B, Ali MA, Proudfoot JA, Koiso T, Nagano O, Carter BS, Serizawa T, Yamamoto M, Chen CC (2016). Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume for Stereotactic Radiosurgery-Treated Brain Metastasis Patients. Neurosurgery, 82(4), 473-480. ()
    56. Carroll KT, Lochte BC, Chen JY, Snyder VS, Carter BS, Chen CC (2018). Intraoperative Magnetic Resonance Imaging-Guided Biopsy in the Diagnosis of Suprasellar Langerhans Cell Histiocytosis. World Neurosurg, 112, 6-13. ()
    57. Ricklefs FL, Alayo Q, Krenzlin H, Mahmoud AB, Speranza MC, Nakashima H, Hayes JL, Lee K, Balaj L, Passaro C, Rooj AK, Krasemann S, Carter BS, Chen CC, Steed T, Treiber J, Rodig S, Yang K, Nakano I, Lee H, Weissleder R, Breakefield XO, Godlewski J, Westphal M, Lamszus K, Freeman GJ, Bronisz A, Lawler SE, Chiocca EA (2018). Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv, 4(3), eaar2766. ()
    58. Carroll KT, Bryant AK, Hirshman B, Alattar AA, Joshi R, Gabel B, Carter BS, Harismendy O, Vaida F, Chen CC (2018). Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection. World Neurosurg, 111, e790-e798. ()
    59. Steed TC, Treiber JM, Brandel MG, Patel KS, Dale AM, Carter BS, Chen CC (2018). Quantification of glioblastoma mass effect by lateral ventricle displacement. Sci Rep, 8(1), 2827. ()
    60. Ali MA, Hirshman BR, Wilson B, Schupper AJ, Joshi R, Proudfoot JA, Goetsch SJ, Alksne JF, Ott K, Aiyama H, Nagano O, Carter BS, Chiang V, Serizawa T, Yamamoto M, Chen CC (2017). Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume. World Neurosurg, 108, 151-156. ()
    61. Ali MA, Hirshman BR, Wilson B, Carroll KT, Proudfoot JA, Goetsch SJ, Alksne JF, Ott K, Aiyama H, Nagano O, Carter BS, Fogarty G, Hong A, Serizawa T, Yamamoto M, Chen CC (2017). Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of Lesions. World Neurosurg, 107, 944-951.e1. ()
    62. Adhikari B, Li J, Brandel MG, Futalan D, Akers J, Deming T, Chen CC, Carter BS (2017). The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts. J Clin Neurosci, 45, 288-292. ()
    63. Wei Z, Batagov AO, Schinelli S, Wang J, Wang Y, El Fatimy R, Rabinovsky R, Balaj L, Chen CC, Hochberg F, Carter B, Breakefield XO, Krichevsky AM (2017). Coding and noncoding landscape of extracellular RNA released by human glioma stem cells. Nat Commun, 8(1), 1145. ()
    64. Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, Cahill D, Bettegowda C, Lang FF, Chiocca EA, Henson J, Kim R, Breakefield X, Chen C, Messer K, Hochberg F, Carter BS (2017). Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol, 19(11), 1494-1502. ()
    65. Ibsen SD, Wright J, Lewis JM, Kim S, Ko SY, Ong J, Manouchehri S, Vyas A, Akers J, Chen CC, Carter BS, Esener SC, Heller MJ (2017). Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma. ACS Nano, 11(7), 6641-6651. ()
    66. Carroll KT, Hirshman B, Ali MA, Alattar AA, Brandel MG, Lochte B, Lanman T, Carter B, Chen CC (2017). Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis. World Neurosurg, 103, 186-193. ()
    67. Schupper AJ, Hirshman BR, Carroll KT, Ali MA, Carter BS, Chen CC (2017). Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis. World Neurosurg, 103, 741-747. ()
    68. Brown JM, Mahan MA, Mandeville R, Carter BS (2017). Establishing reconstructive neurosurgery as a subspecialty. Neurosurg Focus, 43(1), E7. ()
    69. Scheer JK, Hamelin T, Chang L, Lemkuil B, Carter BS, Chen CC (2016). Real-time Magnetic Resonance Imaging-Guided Biopsy Using SmartFrame® Stereotaxis in the Setting of a Conventional Diagnostic Magnetic Resonance Imaging Suite. Oper Neurosurg (Hagerstown), 13(3), 329-337. ()
    70. Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, Zhu W, Li J, Figueroa J, Hirshman BR, Miller B, Piccioni D, Ringel F, Komotar R, Messer K, Galasko DR, Hochberg F, Mao Y, Carter BS, Chen CC (2017). A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget, 8(40), 68769-68779. ()
    71. Saugstad JA, Lusardi TA, Van Keuren-Jensen KR, Phillips JI, Lind B, Harrington CA, McFarland TJ, Courtright AL, Reiman RA, Yeri AS, Kalani MYS, Adelson PD, Arango J, Nolan JP, Duggan E, Messer K, Akers JC, Galasko DR, Quinn JF, Carter BS, Hochberg FH (2017). Analysis of extracellular RNA in cerebrospinal fluid. J Extracell Vesicles, 6(1), 1317577. ()
    72. Steinberg JA, Carter BS, Lee MB, Steinberg GK (2016). Ipsilateral Pupillary Dilation Following Carotid Endarterectomy: A Temporary and Benign Phenomenon. Neurosurgery, 80(5), E239-E244. ()
    73. Brandel MG, Alattar AA, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen CC (2017). Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis. J Neurooncol, 133(1), 173-181. ()
    74. Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, Ghogawala Z, McKhann G 2nd (2015). Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study. Neurosurgery, 80(4), 590-601. ()
    75. Lau SKM, Patel K, Kim T, Knipprath E, Kim GY, Cervio LI, Lawson JD, Murphy KT, Sanghvi P, Carter BS, Chen CC (2017). Clinical efficacy and safety of surface imaging guided radiosurgery (SIG-RS) in the treatment of benign skull base tumors. J Neurooncol, 132(2), 307-312. ()
    76. Brandel MG, Hirshman BR, McCutcheon BA, Tringale K, Carroll K, Richtand NM, Perry W, Chen CC, Carter BS (2016). The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury. J Neurotrauma, 34(5), 1005-1016. ()
    77. Wilson BR, Tringale KR, Hirshman BR, Zhou T, Umlauf A, Taylor WR, Ciacci JD, Carter BS, Chen CC (2016). Depression After Spinal Surgery: A Comparative Analysis of the California Outcomes Database. Mayo Clin Proc, 92(1), 88-97. ()
    78. Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir EG (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clin Cancer Res, 22(24), 6256-6265. ()
    79. Tringale KR, Wilson BR, Hirshman B, Zhou T, Folsom D, Norman MA, Grant I, Chen CC, Carter BS (2016). Psychiatric Disease Preceding Intracranial Tumor Diagnosis: Investigating the Association. Prim Care Companion CNS Disord, 18(6). ()
    80. Hirshman BR, Jones LA, Carroll KT, Tang JA, Proudfoot JA, Carley KM, Carter BS, Chen CC (2016). Coevolution of Peer-Reviewed Literature and Clinical Practice in High-Grade Glioma Resection. World Neurosurg, 96, 237-241. ()
    81. Hirshman BR, Jones LA, Tang JA, Proudfoot JA, Carley KM, Carter BS, Chen CC (2016). 'Journal Bias' in peer-reviewed literature: an analysis of the surgical high-grade glioma literature. J Neurol Neurosurg Psychiatry, 87(11), 1248-1250. ()
    82. Vespa P, Hanley D, Betz J, Hoffer A, Engh J, Carter R, Nakaji P, Ogilvy C, Jallo J, Selman W, Bistran-Hall A, Lane K, McBee N, Saver J, Thompson RE, Martin N, ICES Investigators (2016). ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for Brain Hemorrhage: A Multicenter Randomized Controlled Trial. Stroke, 47(11), 2749-2755. ()
    83. Kerezoudis P, McCutcheon BA, Murphy M, Rayan T, Gilder H, Rinaldo L, Shepherd D, Maloney PR, Hirshman BR, Carter BS, Bydon M, Meyer F, Lanzino G (2016). Predictors of 30-day perioperative morbidity and mortality of unruptured intracranial aneurysm surgery. Clin Neurol Neurosurg, 149, 75-80. ()
    84. Marcus LP, Marshall D, Hirshman BR, McCutcheon BA, Gonda DD, Koiso T, Hattangadi-Gluth JA, Carter BS, Yamamoto M, Chen CC (2015). Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model. Neurosurgery, 79(2), 246-52. ()
    85. Murphy M, Gilder H, McCutcheon BA, Kerezoudis P, Rinaldo L, Shepherd D, Maloney P, Snyder K, Carlson ML, Carter BS, Bydon M, Van Gompel JJ, Link MJ (2016). Increased Operative Time for Benign Cranial Nerve Tumor Resection Correlates with Increased Morbidity Postoperatively. J Neurol Surg B Skull Base, 77(4), 350-7. ()
    86. McCutcheon BA, Kerezoudis P, Porter AL, Rinaldo L, Murphy M, Maloney P, Shepherd D, Hirshman BR, Carter BS, Lanzino G, Bydon M, Meyer F (2016). Coma and Stroke Following Surgical Treatment of Unruptured Intracranial Aneurysm: An American College of Surgeons National Surgical Quality Improvement Program Study. World Neurosurg, 91, 272-8. ()
    87. Taich ZJ, Goetsch SJ, Monaco E, Carter BS, Ott K, Alksne JF, Chen CC (2016). Stereotactic Radiosurgery Treatment of Trigeminal Neuralgia: Clinical Outcomes and Prognostic Factors. World Neurosurg, 90, 604-612.e11. ()
    88. Cloughesy TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu PL, Piccioni D, Walbert T, Chu A, Das A, Diago OR, Gammon D, Gruber HE, Hanna M, Jolly DJ, Kasahara N, McCarthy D, Mitchell L, Ostertag D, Robbins JM, Rodriguez-Aguirre M, Vogelbaum MA (2015). Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma. Sci Transl Med, 8(341), 341ra75. ()
    89. Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, Masliah E, Rissman RA (2016). Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst), 3, 63-72. ()
    90. Marshall DC, Marcus LP, Kim TE, McCutcheon BA, Goetsch SJ, Koiso T, Alksne JF, Ott K, Carter BS, Hattangadi-Gluth JA, Yamamoto M, Chen CC (2016). Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries. J Neurooncol, 128(1), 119-128. ()
    91. Patel KS, Yao Y, Wang R, Carter BS, Chen CC (2015). Intraoperative magnetic resonance imaging assessment of non-functioning pituitary adenomas during transsphenoidal surgery. Pituitary, 19(2), 222-31. ()
    92. Akers JC, Ramakrishnan V, Yang I, Hua W, Mao Y, Carter BS, Chen CC (2016). Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. Cancer Biomark, 17(2), 125-32. ()
    93. Akers JC, Ramakrishnan V, Nolan JP, Duggan E, Fu CC, Hochberg FH, Chen CC, Carter BS (2016). Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF). PLoS One, 11(2), e0149866. ()
    94. Hirshman BR, Tang JA, Jones LA, Proudfoot JA, Carley KM, Marshall L, Carter BS, Chen CC (2016). Impact of medical academic genealogy on publication patterns: An analysis of the literature for surgical resection in brain tumor patients. Ann Neurol, 79(2), 169-77. ()
    95. Laurent LC, Abdel-Mageed AB, Adelson PD, Arango J, Balaj L, Breakefield X, Carlson E, Carter BS, Majem B, Chen CC, Cocucci E, Danielson K, Courtright A, Das S, Abd Elmageed ZY, Enderle D, Ezrin A, Ferrer M, Freedman J, Galas D, Gandhi R, Huentelman MJ, Van Keuren-Jensen K, Kalani Y, Kim Y, Krichevsky AM, Lai C, Lal-Nag M, Laurent CD, Leonardo T, Li F, Malenica I, Mondal D, Nejad P, Patel T, Raffai RL, Rubio R, Skog J, Spetzler R, Sun J, Tanriverdi K, Vickers K, Wang L, Wang Y, Wei Z, Weiner HL, Wong D, Yan IK, Yeri A, Gould S (2015). Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles, 4, 26533. ()
    96. Quinn JF, Patel T, Wong D, Das S, Freedman JE, Laurent LC, Carter BS, Hochberg F, Van Keuren-Jensen K, Huentelman M, Spetzler R, Kalani MY, Arango J, Adelson PD, Weiner HL, Gandhi R, Goilav B, Putterman C, Saugstad JA (2015). Extracellular RNAs: development as biomarkers of human disease. J Extracell Vesicles, 4, 27495. ()
    97. Subramanian SL, Kitchen RR, Alexander R, Carter BS, Cheung KH, Laurent LC, Pico A, Roberts LR, Roth ME, Rozowsky JS, Su AI, Gerstein MB, Milosavljevic A (2015). Integration of extracellular RNA profiling data using metadata, biomedical ontologies and Linked Data technologies. J Extracell Vesicles, 4, 27497. ()
    98. McCutcheon BA, Chang DC, Marcus L, Gonda DD, Noorbakhsh A, Chen CC, Talamini MA, Carter BS (2015). Treatment biases in traumatic neurosurgical care: a retrospective study of the Nationwide Inpatient Sample from 1998 to 2009. J Neurosurg, 123(2), 406-14. ()
    99. McCutcheon BA, Ciacci JD, Marcus LP, Noorbakhsh A, Gonda DD, McCafferty R, Taylor W, Chen CC, Carter BS, Chang DC (2014). Thirty-Day Perioperative Outcomes in Spinal Fusion by Specialty Within the NSQIP Database. Spine (Phila Pa 1976), 40(14), 1122-31. ()
    100. Lai G, Muller KA, Carter BS, Chen CC (2015). Arteriovenous malformation within an isocitrate dehydrogenase 1 mutated anaplastic oligodendroglioma. Surg Neurol Int, 6(Suppl 9), S295-9. ()
    101. Gilder AS, Jones KA, Hu J, Wang L, Chen CC, Carter BS, Gonias SL (2015). Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. J Biol Chem, 290(24), 14798-809. ()
    102. Akers JC, Ramakrishnan V, Kim R, Phillips S, Kaimal V, Mao Y, Hua W, Yang I, Fu CC, Nolan J, Nakano I, Yang Y, Beaulieu M, Carter BS, Chen CC (2015). miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. J Neurooncol, 123(2), 205-16. ()
    103. Shen Y, Li J, Nitta M, Futalan D, Steed T, Treiber JM, Taich Z, Stevens D, Wykosky J, Chen HZ, Carter BS, Becher OJ, Kennedy R, Esashi F, Sarkaria JN, Furnari FB, Cavenee WK, Desai A, Chen CC (2015). Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition. Oncotarget, 6(14), 11751-67. ()
    104. Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R (2015). Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun, 6, 6999. ()
    105. Steed TC, Treiber JM, Patel KS, Taich Z, White NS, Treiber ML, Farid N, Carter BS, Dale AM, Chen CC (2014). Iterative probabilistic voxel labeling: automated segmentation for analysis of The Cancer Imaging Archive glioblastoma images. AJNR Am J Neuroradiol, 36(4), 678-85. ()
    106. Gardiner C, Harrison P, Belting M, Bing A, Campello E, Carter BS, Collier ME, Coumans F, Ettelaie C, van Es N, Hochberg FH, Mackman N, Rennert RC, Thaler J, Rak J, Nieuwland R (2015). Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles, 4, 26901. ()
    107. Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K, Ye WL, Hu BQ, Yan W, Zhang W, Akers J, Ramakrishnan V, Li J, Carter B, Liu YW, Hu HM, Wang Z, Li MY, Yao K, Qiu XG, Kang CS, You YP, Fan XL, Song WS, Li RQ, Su XD, Chen CC, Jiang T (2014). RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res, 24(11), 1765-73. ()
    108. Li J, Taich ZJ, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter BS, Wang R, Mao Y, Jiang T, Chen CC (2014). Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Oncotarget, 5(17), 7342-56. ()
    109. Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S, Saria MG, Brown BD, Piccioni DE, Kesari S (2014). Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study. J Neurooncol, 119(2), 361-8. ()
    110. White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjrnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM (2014). Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res, 74(17), 4638-52. ()
    111. Kushwaha D, Ramakrishnan V, Ng K, Steed T, Nguyen T, Futalan D, Akers JC, Sarkaria J, Jiang T, Chowdhury D, Carter BS, Chen CC (2014). A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas. Oncotarget, 5(12), 4026-39. ()
    112. Gonda DD, Khalessi AA, McCutcheon BA, Marcus LP, Noorbakhsh A, Chen CC, Chang DC, Carter BS (2014). Long-term follow-up of unruptured intracranial aneurysms repaired in California. J Neurosurg, 120(6), 1349-57. ()
    113. Hatefi D, Hirshman B, Leys D, Lejeune JP, Marshall L, Carter BS, Kasper E, Chen CC (2014). Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials. Surg Neurol Int, 5, 72. ()
    114. Marcus LP, McCutcheon BA, Noorbakhsh A, Parina RP, Gonda DD, Chen C, Chang DC, Carter BS (2014). Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). J Neurosurg, 120(5), 1201-11. ()
    115. Gonda DD, Kim TE, Goetsch SJ, Kawabe T, Watanabe S, Alksne JF, Hattangadi JA, Nitta M, Ott K, Hodgens DW, Carter BS, Yamamoto M, Chen CC (2014). Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration. Eur J Cancer, 50(6), 1148-58. ()
    116. Gonda DD, Cheung VJ, Muller KA, Goyal A, Carter BS, Chen CC (2014). The Cancer Genome Atlas expression profiles of low-grade gliomas. Neurosurg Focus, 36(4), E23. ()
    117. Li J, Zhu S, Kozono D, Ng K, Futalan D, Shen Y, Akers JC, Steed T, Kushwaha D, Schlabach M, Carter BS, Kwon CH, Furnari F, Cavenee W, Elledge S, Chen CC (2014). Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma. Oncotarget, 5(4), 882-93. ()
    118. Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC, Carter BS, Chen CC (2013). Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg, 120(1), 31-9. ()
    119. McDuff SG, Taich ZJ, Lawson JD, Sanghvi P, Wong ET, Barker FG 2nd, Hochberg FH, Loeffler JS, Warnke PC, Murphy KT, Mundt AJ, Carter BS, McDonald CR, Chen CC (2013). Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry, 84(12), 1384-91. ()
    120. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S, Kalinina J, Hua W, Kesari S, Mao Y, Breakefield XO, Hochberg FH, Van Meir EG, Carter BS, Chen CC (2013). MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One, 8(10), e78115. ()
    121. Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, Breakefield XO, Skog J (2013). BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids, 2(7), e109. ()
    122. Rabinov JD, Yoo AJ, Ogilvy CS, Carter BS, Hirsch JA (2012). ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas. J Neurointerv Surg, 5(4), 306-10. ()
    123. Waters JD, Rose B, Gonda DD, Scanderbeg DJ, Russell M, Alksne JF, Murphy K, Carter BS, Lawson J, Chen CC (2013). Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. J Neurooncol, 113(3), 467-77. ()
    124. McDonald CR, White NS, Farid N, Lai G, Kuperman JM, Bartsch H, Hagler DJ, Kesari S, Carter BS, Chen CC, Dale AM (2012). Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging. AJNR Am J Neuroradiol, 34(6), 1157-63. ()
    125. Saria MG, Corle C, Hu J, Rudnick JD, Phuphanich S, Mrugala MM, Crew LK, Bota DA, Dan Fu B, Kim RY, Brown T, Feely H, Brechlin J, Brown BD, Drappatz J, Wen PY, Chen CC, Carter B, Lee JW, Kesari S (2013). Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg, 118(6), 1183-7. ()
    126. Akers JC, Gonda D, Kim R, Carter BS, Chen CC (2013). Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol, 113(1), 1-11. ()
    127. Gonda DD, Akers JC, Kim R, Kalkanis SN, Hochberg FH, Chen CC, Carter BS (2013). Neuro-oncologic applications of exosomes, microvesicles, and other nano-sized extracellular particles. Neurosurgery, 72(4), 501-10. ()
    128. Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, Hochberg FH, Breakefield XO, Weissleder R, Lee H (2012). Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med, 18(12), 1835-40. ()
    129. Kong S, Sengupta S, Tyler B, Bais AJ, Ma Q, Doucette S, Zhou J, Sahin A, Carter BS, Brem H, Junghans RP, Sampath P (2012). Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res, 18(21), 5949-60. ()
    130. Waters JD, Sanchez C, Sahin A, Futalan D, Gonda DD, Scheer JK, Akers J, Palanichamy K, Waterman P, Chakravarti A, Weissleder R, Morse B, Marsh N, Furfine E, Chen CC, Carvajal I, Carter BS (2012). CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy. J Neurooncol, 110(1), 37-48. ()
    131. Pan H, Cervio LI, Pawlicki T, Jiang SB, Alksne J, Detorie N, Russell M, Carter BS, Murphy KT, Mundt AJ, Chen C, Lawson JD (2012). Frameless, real-time, surface imaging-guided radiosurgery: clinical outcomes for brain metastases. Neurosurgery, 71(4), 844-51. ()
    132. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, Skog J (2012). RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer, 12, 22. ()
    133. Gonda DD, Kim TE, Warnke PC, Kasper EM, Carter BS, Chen CC (2012). Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis. Surg Neurol Int, 3, 97. ()
    134. Kesari S, Advani SJ, Lawson JD, Kahle KT, Ng K, Carter B, Chen CC (2011). DNA damage response and repair: insights into strategies for radiation sensitization of gliomas. Future Oncol, 7(11), 1335-46. ()
    135. Babu MA, Coumans JV, Carter BS, Taylor WR, Kasper EM, Roitberg BZ, Krauss WE, Chen CC (2011). A review of lumbar spinal instrumentation: evidence and controversy. J Neurol Neurosurg Psychiatry, 82(9), 948-51. ()
    136. Sanchez CE, Tierney TS, Gale JT, Alavian KN, Sahin A, Lee JS, Mulligan RC, Carter BS (2010). Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. J Neurosurg, 114(3), 672-80. ()
    137. Chen T, Carter BS (2011). Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials. Asian J Neurosurg, 6(1), 26-31. ()
    138. Ramakrishnan V, Kushwaha D, Koay DC, Reddy H, Mao Y, Zhou L, Ng K, Zinn P, Carter B, Chen CC (2012). Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas. Cancer Biomark, 10(3-4), 185-93. ()
    139. Grandi P, Fernandez J, Szentirmai O, Carter R, Gianni D, Sena-Esteves M, Breakefield XO (2010). Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells. Cancer Gene Ther, 17(9), 655-63. ()
    140. Curry WT Jr, Carter BS, Barker FG 2nd (2010). Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004. Neurosurgery, 66(3), 427-37; discussion 437-8. ()
    141. Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, Carter BS, Breakefield XO, Toner M, Irimia D (2009). Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip, 10(4), 505-11. ()
    142. Carter BS, Farrell C, Owen C (2009). Microsurgical clip obliteration of middle cerebral aneurysm using intraoperative flow assessment. J Vis Exp, (31). ()
    143. Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, Carter BS (2009). Genetically engineered T cells to target EGFRvIII expressing glioblastoma. J Neurooncol, 94(3), 373-82. ()
    144. Latorre JG, Chou SH, Nogueira RG, Singhal AB, Carter BS, Ogilvy CS, Rordorf GA (2009). Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke, 40(5), 1644-52. ()
    145. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG 2nd (2009). Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery, 64(1), 56-60; discussion 60. ()
    146. Skog J, Wrdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol, 10(12), 1470-6. ()
    147. Szentirmai O, Baker CH, Bullain SS, Lin N, Takahashi M, Folkman J, Mulligan RC, Carter BS (2008). Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation. J Neurosurg, 108(5), 979-88. ()
    148. Huang YQ, Sauthoff H, Herscovici P, Pipiya T, Cheng J, Heitner S, Szentirmai O, Carter B, Hay JG (2007). Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med, 36(1), 262-7. ()
    149. Aghi MK, Eskandar EN, Carter BS, Curry WT Jr, Barker FG 2nd (2007). Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas. Neurosurgery, 61(4), 754-60; discussion 760-1. ()
    150. Sanchez CE, Ogilvy CS, Carter BS (2007). Outcomes studies in cerebrovascular neurosurgery. Neurosurg Focus, 22(3), E11. ()
    151. Nogueira RG, Bodock MJ, Koroshetz WJ, Topcuoglu MA, Carter BS, Ogilvy CS, Pryor JC, Buonanno FS (2007). High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study. Neurocrit Care, 7(3), 194-202. ()
    152. Ogilvy CS, Cheung AC, Mitha AP, Hoh BL, Carter BS (2006). Outcomes for surgical and endovascular management of intracranial aneurysms using a comprehensive grading system. Neurosurgery, 59(5), 1037-42; discussion 1043. ()
    153. Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy CS (2006). Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery, 58(4), 602-11; discussion 602-11. ()
    154. Carter BS, Sheth S, Chang E, Sethl M, Ogilvy CS (2006). Epidemiology of the size distribution of intracranial bifurcation aneurysms: smaller size of distal aneurysms and increasing size of unruptured aneurysms with age. Neurosurgery, 58(2), 217-23; discussion 217-23. ()
    155. Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, Kung AL, Mulligan RC, Carter BS (2006). Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery, 58(2), 365-72; discussion 365-72. ()
    156. Magavi SS, Mitchell BD, Szentirmai O, Carter BS, Macklis JD (2005). Adult-born and preexisting olfactory granule neurons undergo distinct experience-dependent modifications of their olfactory responses in vivo. J Neurosci, 25(46), 10729-39. ()
    157. Barker FG 2nd, Carter BS (2005). Synthesizing medical evidence: systematic reviews and metaanalyses. Neurosurg Focus, 19(4), E5. ()
    158. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, Carter BS, Ogilvy CS, Singhal AB (2005). Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med, 33(7), 1603-9; quiz 1623. ()
    159. Curry WT, McDermott MW, Carter BS, Barker FG 2nd (2005). Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg, 102(6), 977-86. ()
    160. Curry WT Jr, Sethi MK, Ogilvy CS, Carter BS (2003). Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction. Neurosurgery, 56(4), 681-92; discussion 681-92. ()
    161. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ (2005). SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology, 64(6), 1008-13. ()
    162. Barker FG 2nd, Curry WT Jr, Carter BS (2005). Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol, 7(1), 49-63. ()
    163. Hoh BL, Curry WT Jr, Carter BS, Ogilvy CS (2004). Computed tomographic demonstrated infarcts after surgical and endovascular treatment of aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien), 146(11), 1177-83. ()
    164. Hoh BL, Topcuoglu MA, Singhal AB, Pryor JC, Rabinov JD, Rordorf GA, Carter BS, Ogilvy CS (2003). Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery, 55(4), 779-86; discussion 786-9. ()
    165. Szentirmai O, Carter BS (2003). Genetic and cellular therapies for cerebral infarction. Neurosurgery, 55(2), 283-6; discussion 296-7. ()
    166. Hoh BL, Cheung AC, Rabinov JD, Pryor JC, Carter BS, Ogilvy CS (2003). Results of a prospective protocol of computed tomographic angiography in place of catheter angiography as the only diagnostic and pretreatment planning study for cerebral aneurysms by a combined neurovascular team. Neurosurgery, 54(6), 1329-40; discussion 1340-2. ()
    167. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA (2004). Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol, 25(5), 819-26. ()
    168. Chen C, Carter BS (2004). Hemicraniectomy for massive cerebral infarction. Top Stroke Rehabil, 11(2), 7-11. ()
    169. Barker FG 2nd, Amin-Hanjani S, Butler WE, Hoh BL, Rabinov JD, Pryor JC, Ogilvy CS, Carter BS (2003). Age-dependent differences in short-term outcome after surgical or endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000. Neurosurgery, 54(1), 18-28; discussion 28-30. ()
    170. Hoh BL, Carter BS, Ogilvy CS (2003). Incidence of residual intracranial AVMs after surgical resection and efficacy of immediate surgical re-exploration. Acta Neurochir (Wien), 146(1), 1-7; discussion 7. ()
    171. Badjatia N, ODonnell J, Baker JR, Huang D, Ayata C, Greer DM, Carter BS, Ogilvy CS, McDonald CT (2005). Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter. Neurocrit Care, 1(2), 145-56. ()
    172. Hoh BL, Rabinov JD, Pryor JC, Carter BS, Barker FG 2nd (2003). In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume. AJNR Am J Neuroradiol, 24(7), 1409-20. ()
    173. Kalkanis SN, Eskandar EN, Carter BS, Barker FG 2nd (2002). Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes. Neurosurgery, 52(6), 1251-61; discussion 1261-2. ()
    174. Topcuoglu MA, Ogilvy CS, Carter BS, Buonanno FS, Koroshetz WJ, Singhal AB (2003). Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests. J Neurosurg, 98(6), 1235-40. ()
    175. Barker FG 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS (2002). In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery, 52(5), 995-1007; discussion 1007-9. ()
    176. Hoh BL, Carter BS, Putman CM, Ogilvy CS (2002). Important factors for a combined neurovascular team to consider in selecting a treatment modality for patients with previously clipped residual and recurrent intracranial aneurysms. Neurosurgery, 52(4), 732-8; discussion 738-9. ()
    177. Ogilvy CS, Carter BS (2002). Stratification of outcome for surgically treated unruptured intracranial aneurysms. Neurosurgery, 52(1), 82-7; discussion 87-8. ()
    178. Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy CS (2001). Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery, 51(2), 303-9; discussion 309-11. ()
    179. Smith ER, Carter BS, Ogilvy CS (2002). Proposed use of prophylactic decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage patients presenting with associated large sylvian hematomas. Neurosurgery, 51(1), 117-24; discussion 124. ()
    180. Hoh BL, Carter BS, Ogilvy CS (2001). Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy. Neurosurgery, 50(6), 1207-11; discussion 1211-2. ()
    181. McDonald CT, Carter BS, Putman C, Ogilvy CS (2001). Subarachnoid Hemorrhage. Curr Treat Options Cardiovasc Med, 3(5), 429-439. ()
    182. Hoh BL, Putman CM, Budzik RF, Carter BS, Ogilvy CS (2001). Combined surgical and endovascular techniques of flow alteration to treat fusiform and complex wide-necked intracranial aneurysms that are unsuitable for clipping or coil embolization. J Neurosurg, 95(1), 24-35. ()
    183. Kuo CJ, Farnebo F, Yu EY, Christofferson R, Swearingen RA, Carter R, von Recum HA, Yuan J, Kamihara J, Flynn E, DAmato R, Folkman J, Mulligan RC (2001). Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A, 98(8), 4605-10. ()
    184. Hoh BL, Carter BS, Budzik RF, Putman CM, Ogilvy CS (2001). Results after surgical and endovascular treatment of paraclinoid aneurysms by a combined neurovascular team. Neurosurgery, 48(1), 78-89; discussion 89-90. ()
    185. Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA (2000). A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. J Virol, 74(20), 9540-5. ()
    186. Chung RY, Carter BS, Norbash A, Budzik R, Putnam C, Ogilvy CS (2000). Management outcomes for ruptured and unruptured aneurysms in the elderly. Neurosurgery, 47(4), 827-32; discussion 832-3. ()
    187. Carter BS, Buckley D, Ferraro R, Rordorf G, Ogilvy CS (2000). Factors associated with reintegration to normal living after subarachnoid hemorrhage. Neurosurgery, 46(6), 1326-33; discussion 1333-4. ()
    188. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest, 80(1), 99-115. ()
    189. Carter BS, Ogilvy CS, Putman C, Ojemann RG (2000). Selective use of extracranial-intracranial bypass as an adjunct to therapeutic internal carotid artery occlusion. Clin Neurosurg, 46, 351-62. ()
    190. Carter BS, Zervas NT, Chiocca EA (1999). Neurogenetic surgery: current limitations and the promise of gene- and virus-based therapies. Clin Neurosurg, 45, 226-46. ()
    191. Bova GS, Partin AW, Isaacs SD, Carter BS, Beaty TL, Isaacs WB, Walsh PC (1998). Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol, 160(3 Pt 1), 660-3. ()
    192. Ogilvy CS, Carter BS (1998). A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms. Neurosurgery, 42(5), 959-68; discussion 968-70. ()
    193. Carter BS, Ogilvy CS, Candia GJ, Rosas HD, Buonanno F (1997). One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery, 40(6), 1168-75; discussion 1175-6. ()
    194. Brooks JD, Bova GS, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI, Isaacs WB (1996). An uncertain role for p53 gene alterations in human prostate cancers. Cancer Res, 56(16), 3814-22. ()
    195. Ogilvy CS, Carter BS, Kaplan S, Rich C, Crowell RM (1996). Temporary vessel occlusion for aneurysm surgery: risk factors for stroke in patients protected by induced hypothermia and hypertension and intravenous mannitol administration. J Neurosurg, 84(5), 785-91. ()
    196. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC (1993). Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res, 53(17), 3869-73. ()
    197. Isaacs WB, Carter BS, Ewing CM (1991). Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res, 51(17), 4716-20. ()
    198. Quinlan DM, Epstein JI, Carter BS, Walsh PC (1991). Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol, 145(5), 998-1002. ()
    199. Carter BS, Epstein JI, Isaacs WB (1990). Ras gene mutations in human prostate cancer. Cancer Res, 50(21), 6830-2. ()
    200. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990). Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci U S A, 87(22), 8751-5. ()
    201. Carter BS, Carter HB, Isaacs JT (1990). Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate, 16(3), 187-97. ()
    202. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990). Family history and the risk of prostate cancer. Prostate, 17(4), 337-47. ()

    Review

    1. Hsia T, Small JL, Yekula A, Batool SM, Escobedo AK, Ekanayake E, You DG, Lee H, Carter BS, Balaj L (2023). Systematic Review of Photodynamic Therapy in Gliomas. [Review]. Cancers (Basel), 15(15). ()
    2. Batool SM, Hsia T, Khanna SK, Gamblin AS, Rosenfeld Y, You DG, Carter BS, Balaj L (2022). Decoding vesicle-based precision oncology in gliomas. [Review]. Neurooncol Adv, 4(Suppl 2), ii53-ii60. ()
    3. Dhawan S, Venteicher AS, Butler WE, Carter BS, Chen CC (2021). Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis. [Review]. J Neurooncol, 154(1), 1-11. ()
    4. Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter BS (2020). Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas. [Review]. Adv Biosyst, 4(12), e2000029. ()
    5. Kozin ED, Remenschneider AK, Blevins NH, Jan TA, Quesnel AM, Chari DA, Kesser BW, Weinstein JE, Ahsan SF, Telischi FF, Adunka OF, Weber P, Knoll RM, Coelho DH, Anne S, Franck KH, Marchioni D, Barker FG 2nd, Carter BS, Lustig LR, Bojrab DI, Bhansali SA, Westerberg BD, Lundy L, Jackler RK, Roland JT Jr, Chandrasekhar SS, Antonelli PJ, Carey JP, Welling DB, Slattery WH 3rd, Lee DJ, members of the American Neurotology Society Council, members of the American Otological Society Council, and members of the American Academy of Otolaryngology Head and Neck Surgery Hearing Committee and Implantable Hearing Devices Committee (2020). American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic. [Review]. Otol Neurotol, 41(9), 1163-1174. ()
    6. Yekula A, Muralidharan K, Kang KM, Wang L, Balaj L, Carter BS (2020). From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers. [Review]. Methods, 177, 58-66. ()
    7. Yekula A, Yekula A, Muralidharan K, Kang K, Carter BS, Balaj L (2020). Extracellular Vesicles in Glioblastoma Tumor Microenvironment. [Review]. Front Immunol, 10, 3137. ()
    8. Roy S, Lin HY, Chou CY, Huang CH, Small J, Sadik N, Ayinon CM, Lansbury E, Cruz L, Yekula A, Jones PS, Balaj L, Carter BS (2019). Navigating the Landscape of Tumor Extracellular Vesicle Heterogeneity. [Review]. Int J Mol Sci, 20(6). ()
    9. Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim KS (2018). Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. [Review]. Prog Neurobiol, 168, 1-20. ()
    10. Patel KS, Dhawan S, Wang R, Carter BS, Chen JY, Chen CC (2018). Post-operative imaging assessment of non-functioning pituitary adenomas. [Review]. Acta Neurochir (Wien), 160(5), 1029-1039. ()
    11. Patel KS, Carter BS, Chen CC (2017). Role of Biopsies in the Management of Intracranial Gliomas. [Review]. Prog Neurol Surg, 30, 232-243. ()
    12. Santiago-Dieppa DR, Gonda DD, Cheung VJ, Steinberg JA, Carter BS, Chen CC (2018). Extracellular Vesicles as a Platform for Glioma Therapeutic Development. [Review]. Prog Neurol Surg, 32, 172-179. ()
    13. Shankar GM, Balaj L, Stott SL, Nahed B, Carter BS (2017). Liquid biopsy for brain tumors. [Review]. Expert Rev Mol Diagn, 17(10), 943-947. ()
    14. Rennert RC, Santiago-Dieppa DR, Figueroa J, Sanai N, Carter BS (2016). Future directions of operative neuro-oncology. [Review]. J Neurooncol, 130(2), 377-382. ()
    15. van Vugt VA, Kesari A, Muller KA, Carter B, Vandenberg SR, Kesari S (2016). A 22-Year Old Woman with Right Eyelid Swelling. [Review]. Brain Pathol, 26(3), 425-6. ()
    16. Rennert RC, Hochberg FH, Carter BS (2016). ExRNA in Biofluids as Biomarkers for Brain Tumors. [Review]. Cell Mol Neurobiol, 36(3), 353-60. ()
    17. Hirshman BR, Kras RT, Akers JC, Carter BS, Chen CC (2016). Extracellular Vesicles in Molecular Diagnostics: An Overview with a Focus on CNS Diseases. [Review]. Adv Clin Chem, 76, 37-53. ()
    18. Santiago-Dieppa DR, Steinberg J, Gonda D, Cheung VJ, Carter BS, Chen CC (2014). Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients. [Review]. Expert Rev Mol Diagn, 14(7), 819-25. ()
    19. Hochberg FH, Atai NA, Gonda D, Hughes MS, Mawejje B, Balaj L, Carter RS (2014). Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. [Review]. Expert Rev Mol Diagn, 14(4), 439-52. ()
    20. Ng K, Kim R, Kesari S, Carter B, Chen CC (2011). Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights. [Review]. J Neurooncol, 107(1), 1-12. ()
    21. McDonald C, Carter BS (2002). Medical management of increased intracranial pressure after spontaneous intracerebral hemorrhage. [Review]. Neurosurg Clin N Am, 13(3), 335-8. ()
    22. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC (1993). Hereditary prostate cancer: epidemiologic and clinical features. [Review]. J Urol, 150(3), 797-802. ()

    Case Report

    1. Mahta A, Du Z, Borys E, Carter B, Vandenberg SR, Kesari S (2013). 78 year old male with dysphagia and dysarthria. Brain Pathol, 23(6), 705-6. ()
    2. Carter BS, Rabinov JD, Pfannl R, Schwamm LH (2004). Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-2004 - a 57-year-old man with slurred speech and left hemiparesis. N Engl J Med, 350(7), 707-16. ()

    Editorial

    1. Carter BS, Chiocca EA (2020). Editorial. COVID-19 and academic neurosurgery. J Neurosurg, 133(1), 8-9. ()
    2. Salehi A, Chen CC, Carter BS (2012). Viral vectors: promising new therapeutics in the battle against glioblastoma. Expert Rev Clin Pharmacol, 5(5), 489-91. ()

    Letter

    1. Schweitzer JS, Herrington TM, Kim KS, Carter BS (2022). Letter to the Editor. Cell therapy for Parkinson's disease. [Letter to the editor]. J Neurosurg, 136(6), 1810-1811. ()
    2. Herrington TM, Schweitzer J, Henchcliffe C, Carter BS, Kim KS (2020). Toward a Personalized Approach to Parkinson's Cell Therapy. [Letter to the editor]. Mov Disord, 35(11), 2119-2120. ()

    Other

    1. Chen CC, Carter BS, Wang R, Patel KS, Hess C, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Zada G, Aghi MK (2016). Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Preoperative Imaging Assessment of Patients With Suspected Nonfunctioning Pituitary Adenomas. Neurosurgery (79(4), pp. E524-6). United States. ()
    2. Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM, Oyesiku NM, Patel KS, Wang R, Carter BS, Chen JY, Chen CC, Patil CG, Litvack Z, Zada G, Aghi MK (2016). Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. Neurosurgery (79(4), pp. E541-3). United States. ()
    3. Wilson BR, Steinberg JA, Snyder V, Jiang MN, Carter BS (2016). Histologic Evidence for Arteriovenous Malformation-Like Vasculature Occurring within an Intracerebral Schwannoma: A Case Report and Review of the Literature. World Neurosurg (92, pp. 582.e9-582.e13). United States. ()
    4. Carter BS, Chiocca EA, Lonser R, Kaye AH, de Tribolet N (2015). Introduction: a focus on low-grade glioma. Neurosurg Focus (38(1), pp. E2). United States. ()
    5. Wijdicks EF, Sheth KN, Carter BS, Greer DM, Kasner SE, Kimberly WT, Schwab S, Smith EE, Tamargo RJ, Wintermark M, American Heart Association Stroke Council (2014). Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (45(4), pp. 1222-38). United States. ()
    6. Akers JC, Gonda D, Kim R, Carter BS, Chen CC (2013). Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol (113(1), pp. 1-11). United States. ()

  • News & Podcasts

    News